Electrophoresis Market Size, Share, and Trends 2025 to 2034

The electrophoresis market is projected to grow from USD 2.60 billion in 2025 to USD 4.17 billion by 2034, at a CAGR of 5.38%. Growth is fueled by increased demand in genetic diagnostics, pharmaceutical research, and biotechnology. The Asia Pacific region is expected to witness the fastest growth, while reagents and pharmaceutical applications continue to dominate the market. Rising adoption of personalized medicine and industry-academia collaboration are expanding opportunities.

Last Updated : June 2025  |  Report Code : 3659  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Electrophoresis Market 

5.1. COVID-19 Landscape: Electrophoresis Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Electrophoresis Market, By Product

8.1. Electrophoresis Market Revenue and Volume, by Product

8.1.1 Electrophoresis Systems

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Gel Documentation Systems and Software

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Electrophoresis Reagents

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Electrophoresis Market, By End User

9.1. Electrophoresis Market Revenue and Volume, by End User

9.1.1. Academic Institutions

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Hospitals and Diagnostic Centers

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Pharmaceutical and Biotechnology Companies

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Research Organizations

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global Electrophoresis Market, By Application 

10.1. Electrophoresis Market Revenue and Volume, by Application

10.1.1. Diagnostic

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Research

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Quality Control and Process Validation

10.1.3.1. Market Revenue and Volume Forecast

Chapter 11. Global Electrophoresis Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product

11.1.2. Market Revenue and Volume Forecast, by End User

11.1.3. Market Revenue and Volume Forecast, by Application

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product

11.1.4.2. Market Revenue and Volume Forecast, by End User

11.1.4.3. Market Revenue and Volume Forecast, by Application

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product

11.1.5.2. Market Revenue and Volume Forecast, by End User

11.1.5.3. Market Revenue and Volume Forecast, by Application

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product

11.2.2. Market Revenue and Volume Forecast, by End User

11.2.3. Market Revenue and Volume Forecast, by Application

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product

11.2.4.2. Market Revenue and Volume Forecast, by End User

11.2.4.3. Market Revenue and Volume Forecast, by Application

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product

11.2.5.2. Market Revenue and Volume Forecast, by End User

11.2.5.3. Market Revenue and Volume Forecast, by Application

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product

11.2.6.2. Market Revenue and Volume Forecast, by End User

11.2.6.3. Market Revenue and Volume Forecast, by Application

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product

11.2.7.2. Market Revenue and Volume Forecast, by End User

11.2.7.3. Market Revenue and Volume Forecast, by Application

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product

11.3.2. Market Revenue and Volume Forecast, by End User

11.3.3. Market Revenue and Volume Forecast, by Application

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product

11.3.4.2. Market Revenue and Volume Forecast, by End User

11.3.4.3. Market Revenue and Volume Forecast, by Application

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product

11.3.5.2. Market Revenue and Volume Forecast, by End User

11.3.5.3. Market Revenue and Volume Forecast, by Application

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product

11.3.6.2. Market Revenue and Volume Forecast, by End User

11.3.6.3. Market Revenue and Volume Forecast, by Application

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product

11.3.7.2. Market Revenue and Volume Forecast, by End User

11.3.7.3. Market Revenue and Volume Forecast, by Application

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product

11.4.2. Market Revenue and Volume Forecast, by End User

11.4.3. Market Revenue and Volume Forecast, by Application

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product

11.4.4.2. Market Revenue and Volume Forecast, by End User

11.4.4.3. Market Revenue and Volume Forecast, by Application

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product

11.4.5.2. Market Revenue and Volume Forecast, by End User

11.4.5.3. Market Revenue and Volume Forecast, by Application

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product

11.4.6.2. Market Revenue and Volume Forecast, by End User

11.4.6.3. Market Revenue and Volume Forecast, by Application

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product

11.4.7.2. Market Revenue and Volume Forecast, by End User

11.4.7.3. Market Revenue and Volume Forecast, by Application

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product

11.5.2. Market Revenue and Volume Forecast, by End User

11.5.3. Market Revenue and Volume Forecast, by Application

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product

11.5.4.2. Market Revenue and Volume Forecast, by End User

11.5.4.3. Market Revenue and Volume Forecast, by Application

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product

11.5.5.2. Market Revenue and Volume Forecast, by End User

11.5.5.3. Market Revenue and Volume Forecast, by Application

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agilent Technologies, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Bio-Rad Laboratories, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. QIAGEN N.V.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Merck KGaA

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GE Healthcare

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. PerkinElmer, Inc.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Lonza Group Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Harvard Bioscience, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Danaher Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global electrophoresis market size is expected to increase USD 4.17 billion by 2034 from USD 2.47 billion in 2024.

The global electrophoresis market will register growth rate of 5.38% between 2025 and 2034.

The major players operating in the electrophoresis market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, GE Healthcare, PerkinElmer, Inc., Lonza Group Ltd., Harvard Bioscience, Inc., Danaher Corporation, Promega Corporation, SCIEX, miniPCR bio, Cleaver Scientific Ltd., Sebia Group, and Others.

The driving factors of the electrophoresis market is the growing industry-academia research collaborations.

North America region will lead the global electrophoresis market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client